AmerisourceBergen Corporation sources and distributes pharmaceutical products to healthcare providers, pharmaceutical and biotech manufacturers, and specialty drug patients in the United States and internationally. The company was founded in 1985 and is based in Chesterbrook, Pennsylvania.
ABC Price Forecast Based on DCF Valuation
DCF Fair Value Target:
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Amerisourcebergen Corp. To summarize, we found that Amerisourcebergen Corp ranked in the 72th percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 335.33%. As for the metrics that stood out in our discounted cash flow analysis of Amerisourcebergen Corp, consider:
Its compound free cash flow growth rate, as measured over the past 5.48 years, is 0.34% -- higher than 76.66% of stocks in our DCF forecasting set.
The weighted average cost of capital for the company is 7. This value is greater than only 17.82% stocks in the Healthcare sector that generate free cash flow.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
Want more companies with a valuation profile/forecast similar to that of Amerisourcebergen Corp? See CVS, ALXN, INVA, BLFS, and CCEL.